|
|
||||||||
1 Division of Nephrology, University of Maryland School of Medicine, Baltimore, Maryland 21201-1595; and 2 Cardiovascular Research Institute, University of Leicester, Leicester LE1 7RH, United Kingdom
| |
ABSTRACT |
|---|
|
|
|---|
We investigated the dependence of ANG II
(10
8 M)-induced constriction of outer medullary
descending vasa recta (OMDVR) on membrane potential (
m) and chloride
ion. ANG II depolarized OMDVR, as measured by fully loading them with
the voltage-sensitive dye bis[1,3-dibutylbarbituric
acid-(5)] trimethineoxonol
[DiBAC4(3)] or selectively loading their pericytes. ANG
II was also observed to depolarize pericytes from a resting value of
55.6 ± 2.6 to
26.2 ± 5.4 mV when measured with
gramicidin D-perforated patches. When measured with
DiBAC4(3) in unstimulated vessels, neither changing
extracellular Cl
concentration ([Cl
]) nor
exposure to the chloride channel blocker indanyloxyacetic acid 94 (IAA-94; 30 µM) affected
m. In contrast, IAA-94 repolarized OMDVR pretreated with ANG II. Neither IAA-94 (30 µM) nor niflumic acid (30 µM, 1 mM) affected the vasoactivity of unstimulated
OMDVR, whereas both dilated ANG II-preconstricted vessels. Reduction of
extracellular [Cl
] from 150 to 30 meq/l enhanced ANG
II-induced constriction. Finally, we identified a Cl
channel in OMDVR pericytes that is activated by ANG II or by excision
into extracellular buffer. We conclude that constriction of OMDVR by
ANG II involves pericyte depolarization due, in part, to increased
activity of chloride channels.
medulla; kidney; microcirculation; membrane potential; patch clamp; niflumic acid; indanyloxyacetic acid 94
| |
INTRODUCTION |
|---|
|
|
|---|
DESCENDING VASA RECTA (DVR) supply blood flow to the medulla of the kidney (25, 27). These microvessels arise from juxtamedullary efferent arterioles in the outer medulla and collect into vascular bundles as they descend toward the papilla. DVR on the periphery of each vascular bundle peel off to supply the outer medulla, whereas central DVR supply the inner medulla.
DVR are vasoactive and might regulate the distribution of blood flow within the renal medulla. ANG II constricts DVR isolated from rat kidneys and perfused in vitro, apparently by contracting smooth muscle-like pericytes surrounding the endothelium of these microvessels (24, 25, 30). This vasoactivity suggests that DVR could redistribute blood flow between the outer and inner medulla, given the anatomy described above (20, 27). The distribution of renal medullary blood flow may influence natriuresis and the long-term control of arterial pressure (7).
The electrophysiology of constriction of the efferent arterioles from DVR appears to be different from that in most types of vascular smooth muscle. Most descriptions of the actions of ANG II and other vasoconstrictors have shown that contraction of vascular smooth muscle involves depolarization of plasma membranes, often through activation of chloride channels (13, 17-19, 26, 27, 36). This depolarization promotes smooth muscle contraction by activating voltage-sensitive calcium channels in the plasma membrane and so increasing Ca2+ influx, even though it reduces the electrical force driving cation entry (1, 9). This seems true of smooth muscle in systemic vessels (17-19, 36) and renal afferent arterioles (5) and also of mesangium in glomeruli (22, 33). In contrast, ANG II constricts renal efferent arterioles without consistently depolarizing their smooth muscle (21) and in the presence of chloride channel blockers (6). We have examined how ANG II constricts isolated outer medullary DVR (OMDVR), using a voltage-sensitive dye, patch-clamp recording, and measurement of vasoactivity.
| |
METHODS |
|---|
|
|
|---|
Isolation of OMDVR.
Kidneys were removed from Sprague-Dawley rats (70-150 g; Harlan),
which had been anesthetized with intraperitoneal thiopental sodium (50 mg/kg body wt). Renal slices were stored at 4°C in a solution of (in
mM): 150 NaCl, 10 Na acetate, 5 KCl, 1.2 MgSO

Fluorescence microscopy.
Changes of membrane potential (
m) in OMDVR were monitored by
fluorescent microscopy of isolated, nonperfused microvessels exposed to
bis[1,3-dibutylbarbituric acid-(5)] trimethineoxonol [DiBAC4(3)] in the bath solution. DiBAC4(3)
is a lipophilic anion that becomes fluorescent on binding proteins or
cell membranes (4, 10, 14, 35). Hyperpolarization reduces
the fluorescence of cells exposed to DiBAC4(3), and
depolarization increases fluorescence by changing the intracellular
concentration of the anionic dye. We included DiBAC4(3) in
the solution used to store renal slices before fluorescence
investigations, because when OMDVR were exposed to
DiBAC4(3) for the first time during experiments, continuous loading rapidly increased fluorescence and obscured our observation of
responses of
m.
Fluorescence calibration.
The relationship between
m and DiBAC4(3) fluorescence
was calibrated in OMDVR exposed to gramicidin D, an ionophore for
monovalent cations.
m was calculated using the Goldman equation, by
assuming that gramicidin D equalizes membrane permeability to
K+ and Na+ (10, 14, 35),
|
(1) |

Limitations of fluorescence.
Changes of
m in OMDVR bathed in DiBAC4(3) can be
obscured by variations in fluorescence due to fluctuations in fluid
level during solution exchanges. DiBAC4(3) in the bath
typically emitted background fluorescence of ~25% of the total
signal, even without albumin. Exchange artifacts were minimized in two
ways. First, ANG II was delivered by merging two streams. One stream
provided bath flow to the chamber. A second pump was turned on at the
required point in the experiment to deliver a solution of appropriate
ANG II concentration (in bathing buffer) to be diluted into the first stream. The ratio of the flow of the two streams was 1:23. Second, when
it was necessary to completely exchange the bath, bathing buffer was
delivered from two 30-ml syringes whose plungers were driven
simultaneously on a single syringe pump. The streams from the syringes
were directed to either a collection flask or the perfusion chamber. By
switching a stopcock, we could rapidly alternate the destinations of
the two streams without affecting bath flow rate.
30°C) charge-coupled device sensor head (Kodak
KAF0400-0). These images show that fluorescence comes from both
endothelium and pericytes in OMDVR exposed to bath
DiBAC4(3) (Fig.
1A).
|
10 mmHg. Each pericyte was superfused with DiBAC4(3) from an inner
concentric pipette brought to within a few microns of the cell body.
With this scheme, DiBAC4(3) was omitted from the bath.
Fluorescence was monitored as ANG II was introduced into the bath
during continuous DiBAC4(3) superfusion.
Patch-clamp recording.
Whole cell
m and single-channel activity were monitored by
patch-clamp recording from pericyte cell bodies on isolated,
nonperfused OMDVR at room temperature. These OMDVR had been treated to
digest basement membrane and assist gigaohm sealing of patch pipettes onto pericytes (2, 31). Small wedges of renal outer
medulla were separated from kidney slices in calcium-free PBS
containing EGTA (in mM): 145 NaCl, 5.4 KCl, 1 MgCl2, 0 CaCl2, 10 HEPES, 10 glucose, and 0.1 EGTA. The tissue was
incubated in the same solution for 1 h at 4°C and then
transferred to PBS without EGTA for an additional hour. After this, the
wedges were placed in calcium-free PBS containing papain (0.6 mg/ml)
and dithiothreitol (0.5 mg/ml) for 20 min at 4°C. The tissue was then
digested at 37°C for 20 min in calcium-free PBS containing
collagenase 1A (0.5 mg/ml; Sigma), protease XIV (0.4 mg/ml; Sigma), and
albumin (0.8 mg/ml). OMDVR from the digested tissue were stored in PBS
containing 0.1 mM CaCl2 and transferred to the cell bath on
an inverted microscope for patch-clamp recordings.
m was measured using a CV201AU
headstage and Axopatch 200A amplifier (Axon Instruments, Foster City,
CA) in current clamp mode (I = 0), recorded on videotape (VR-10B
digital data recorder, Instrutech, Great Neck, NY and Panasonic AG 2550 VCR) and later sampled at 2 kHz using a Digidata 1200 interface.
For single-channel recording, the pipette contained CsCl solution (in
mM): 150 CsCl and 10 HEPES, pH 7.2. The extracellular solution (bath)
contained (in mM): 145 NaCl, 5.4 KCl, 1 MgCl2, 1 CaCl2, 10 glucose, and 10 HEPES, pH 7.4. Single-channel
data were filtered at 1 kHz and sampled at 5 kHz. Open probabilities (Popen) were calculated by analyzing 2-min records using pSTAT (Axon
Instruments). Dwell time (Ti) for the ith level
was determined and Popen calculated from the formula Popen =
(Ti/To)/N, where To is total time of observation and N
is the number of channels observed in the patch.
Vasoactivity.
Changes in diameter of OMDVR were monitored by white light microscopy
of isolated, perfused microvessels and recorded on videotape (24). The inverted microscope supporting the chamber
contained a beam splitter and a side port for attachment of a video
camera (Panasonic WV-BL90) linked to a Panasonic model AG 1960 VCR with a microphone for voice recording. OMDVR were imaged using a ×40 objective, and the final magnification on the video screen was ×1,300.
Internal diameters were measured using calipers at the position where
the vessel constricted most. Diameter changes are expressed as percent
constriction, given by [1
(D/Do)] × 100, where D is
experimental diameter and Do is initial baseline diameter. The
perfusion and bath solutions used for monitoring vasoactivity had the
same composition as dissection solution (with CaCl2). The
pH was adjusted with NaOH to 7.55 at room temperature to yield a pH of
~7.4 at 37°C.
Reagents.
ANG II, bovine serum albumin (A2153, Cohn fraction V), gramicidin D,
collagenase 1A, and protease XIV came from Sigma. ANG II
(10
5 M) in water was stored in 100-µl aliquots at
20°C and diluted on the day of experiment. DiBAC4(3) (5 mM; Molecular Probes, Eugene, OR) in DMSO was stored at
20°C in
lightproof containers and diluted to a concentration of 4 µM in
experimental solutions. The chloride channel blockers, indanyloxyacetic
acid 94 (IAA-94) and niflumic acid, were also stored in aliquots in
DMSO and diluted on the day of an experiment. Reagents were frozen and
thawed once only. Excess reagents were discarded at the end of each
experimental day.
Statistics. Except where otherwise specified, data in the text or figures are given as means ± SE. The significance of differences between means was calculated using Student's t-test (paired or unpaired, as appropriate) and repeated-measures analysis of variance. In the figures, straight lines through groups of data were drawn by regression analysis. In figures that show DiBAC4(3) fluorescence, data were sampled every 2 s, but the error bars associated with most of the points have been suppressed for clarity.
| |
RESULTS |
|---|
|
|
|---|
DiBAC4(3) calibration.
The calibration of DiBAC4(3) with gramicidin D is shown
Fig. 2. Fluorescence increases with
depolarization, as calculated from equation 1. The slope is
0.37%/mV, which resembles published values for this class of dyes
(14, 35). Calculation of
m from equation 1 requires [K+]i. As illustrated in Fig. 2,
predictions are insensitive to [K+]i when it
is taken to be between the reasonable limits of 100 and 150 mM.
|
Effect of K+ and
Cl
alterations on resting potential.
Increasing bath KCl concentration from 5 to 30 mM by isosmolar
substitution for NaCl increased fluorescence, indicating depolarization of DiBAC4(3) loaded cells (Fig.
3). When normalized fluorescence for
sham-exchanged controls was subtracted, an ~18% increase in fluorescence resulted from KCl corresponding to a 48-mV depolarization. This must be taken as a weighted average for the endothelia and pericytes. If one assumes that K+ conductance is the sole
determinant of
m, then changing from 5 to 30 mM KCl in the bath
yields a theoretical depolarization of 47.7 mV when
[K+]i is assumed to be either 100 or 150 mM.
Chloride channel activity influences
m in many cell types, including
smooth muscle (19, 35) and endothelia (1,
23). To test for a possible role of Cl
conductance
in OMDVR, bath [Cl
] was reduced from 150 to 30 mM by
isosmolar substitution with Na acetate (Fig. 3). No significant change
in fluorescent signal was observed in the absence of ANG II
stimulation.
|
Effects of ANG II on
m.
Compared with controls, abluminal application of ANG II
(10
8 M) from the bath increased the fluorescence of fully
DiBAC4(3)-loaded vessels by 8.0% (Fig.
4), corresponding to depolarization of
21.6 mV. When DiBAC4(3) was selectively superfused onto the
pericytes (Fig. 1B), ANG II (10
8 M) also
depolarized the cells by 9.2%, corresponding to depolarization of 24.9 mV. To corroborate the finding of pericyte depolarization, we measured
the effect of ANG II on
m by whole cell patch-clamp recording. In
these experiments, performed at room temperature, ANG II
(10
8 M) depolarized the pericyte plasma membrane by an
average of 29.4 mV, from a resting potential of
55.6 ± 2.6 to
26.2 ± 5.4 mV, P < 0.05 (Fig.
5).
|
|
Effect of chloride channel inhibitors on
m.
To determine whether ANG II-induced depolarization is mediated by
Cl
channels, the effects of IAA-94 on
DiBAC4(3) fluorescence were examined in ANG II-pretreated
vessels. In support of the lack of effect of Cl
substitution observed in Fig. 3, IAA-94 did not alter
DiBAC4(3) fluorescence in OMDVR that had not been exposed
to ANG II. In contrast, IAA-94 repolarized ANG II-pretreated vessels,
implying that Cl
conductance contributes significantly to
m when ANG II receptors are occupied (Fig.
6). We tested the effects of IAA-94 and
the calcium-activated chloride channel blocker niflumic acid on
vasoactivity, but we could not examine the effect of niflumic acid on
DiBAC4(3) because it seemed to destroy
DiBAC4(3) fluorescence.
|
Effect of chloride channel inhibitors on ANG II-induced
vasoconstriction.
To test whether chloride channel activity is necessary for ANG
II-induced vasoconstriction, the effects of two chloride channel blockers, IAA-94 and niflumic acid, were examined. In a first series,
ANG II (10
8 M) was introduced into the bath for 5 min,
following which either IAA-94 (3 × 10
5 M) or
vehicle was added for an additional 5 min and then removed (Fig.
7A). As is typical for ANG II,
vasoconstriction maximized and then waned somewhat in vessels treated
with ANG II alone. In comparison, reversal of vasoconstriction occurred
in vessels treated with IAA-94. Partial return to the vasoconstricted
state was achieved after removal of IAA-94 from the bath, but washout was slow. Slow reversal of the effects of this lipophilic agent has
been described by others (3). We also tested the effects of the chloride channel inhibitor niflumic acid. At both 1 mM (data not
shown) and 30 µM, niflumic acid inhibited ANG II-induced OMDVR
constriction (Fig. 7B). The reversal of ANG II-induced
vasoconstriction by niflumic acid was rapidly eliminated with washout
(Fig. 7B). Neither IAA-94 nor niflumic acid had significant
effects on OMDVR that had not been preconstricted by ANG II (Fig. 7,
A and B).
|
Effect of Cl
substitution on ANG II-induced
vasoconstriction.
To test further whether chloride conductance is important for ANG
II-induced vasoconstriction, we enhanced the electrochemical driving
force favoring Cl
efflux from the pericytes by reducing
the [Cl
]o of the bath from 150 to 30 mM. In
these experiments, the collection end of the vessel was crimped to
minimize perfusion and therefore any bath to lumen gradients of
Cl
. As shown in Fig. 8, the
waning of vasoconstriction observed with ANG II in controls was
completely reversed when extracellular Cl
was reduced.
Subsequent return of [Cl
]o to 150 mM at 15 min dilated the vessels.
|
Single channels activated by ANG II in pericytes on OMDVR.
Single-channel currents from cell-attached and -excised patches are
illustrated in Fig. 9, A and
B, respectively. ANG II activated these channels in
pericytes on isolated OMDVR, during recording from cell-attached
patches (Fig. 9, A and C). Single-channel
currents in cell-attached and -excised patches are summarized in Fig.
10. In excised patches exposed to
nearly symmetrical chloride concentrations in the pipette and bath and
to Cs+ and Na+ as cations, reversal potential
was near zero (Fig. 10, A and B). This is
consistent with currents through chloride channels or poorly selective
cation channels. Interestingly, this channel appeared to activate on
excision without rundown over 10 to 15 min (Figs. 9B and
10C). In cell-attached patches, with CsCl in the pipette
(but no Na+ or K+), currents also reversed near
a pipette potential of zero (Fig. 10D). This indicates that
Cl
is the main conducting ion, because for
[Cl
]i, ~20- to 30-mM reversal is expected
to occur at approximately
50 mV, which is the resting
m of these
cells (Fig. 5). These channels were too rarely found in patches to
permit a more detailed study of their properties. When observed, it was
common to find two or three channels per patch.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Substantial evidence has been provided to show that ANG II exerts a tonic influence on perfusion of the renal medulla (8, 11, 32). Motivated by this, we have investigated the mechanisms involved in constriction of OMDVR by ANG II. Our data indicate that ANG II constriction involves depolarization of the contractile pericytes, at least, in part, through activation of chloride channels. Thus the electrophysiology of the pericytes resembles that of smooth muscle from most blood vessels. The evidence that ANG II depolarizes OMDVR is that it reduces fluorescence from microvessels loaded with DiBAC4(3) (Figs. 1 and 4), a voltage-sensitive dye. The evidence that ANG II depolarizes pericytes is that it reduces fluorescence from pericyte cell bodies selectively loaded with DiBAC4(3) (Figs. 1B and 4), and this is supported by patch-clamp measurements (Fig. 5).
ANG II depolarizes OMDVR apparently by activating chloride channels,
because a chloride channel blocker inhibits this depolarization (Fig.
6). Chloride channels in OMDVR seem inactive without ANG II, because
resting
m is insensitive to [Cl
]o (Fig.
3) or IAA-94 (Fig. 6). At least some of these channels may be
in pericytes, where patch-clamp recording reveals probable chloride
channels barely active until stimulated by ANG II (Figs. 9 and 10). ANG
II constriction of OMDVR apparently involves a depolarizing chloride
current, because chloride channel blockers inhibit constriction (Fig.
7) and reduction of [Cl
]o to favor a
depolarizing current enhancing constriction (Fig. 8). Given the
incomplete reversal of vasoconstriction by chloride channel blockade
(Fig. 7), other actions besides depolarization may be necessary for ANG
II to induce OMDVR vasoconstriction.
This evidence has limitations. First, monitoring
m by patch clamping
requires enzymatic digestion to enable gigaohm sealing, and this might
modify receptors or ion channels in pericytes. Second,
DiBAC4(3) fluorescence depends to an unknown extent on a
contaminating signal from intracellular membranes. Third, to minimize
background fluorescence, monitoring
m using DiBAC4(3) requires removal of albumin from the bath, and this may modify endothelial responses (12). Fourth, we do not know the
contributions of pericytes and endothelium to fluorescence from OMDVR
bathed in DiBAC4(3) (Figs. 1 and 4). Even after selective
loading of pericytes (Fig. 1B), some DiBAC4(3)
might diffuse to the endothelium.
Constriction of OMDVR by ANG II might involve depolarization of endothelium as well as pericytes. In endothelia, which generally do not express voltage-dependent calcium channels (1, 9), depolarization would reduce Ca2+ influx by reducing the electrical force driving cation entry. This would be expected to reduce endothelial [Ca2+]i and to inhibit release of calcium-dependent vasodilators, such as nitric oxide and prostacyclin. We have recently provided evidence that ANG II reduces endothelial [Ca2+]i in OMDVR and inhibits bradykinin and thapsigargin-induced [Ca2+]i elevations (28).
If pericytes surrounding OMDVR contract when depolarized via activation
of chloride channels, then they resemble many types of vascular smooth
muscle. Chloride channels influence
m in smooth muscle
(17-19, 36, 37) and mesangium (22, 33)
as well as in endothelium (23). Vasoconstrictors act on
renal vascular smooth muscle by activating chloride currents and
inducing depolarization (13, 34). Gordienko and colleagues
(13) provided an extensive dissection of whole cell
currents in smooth muscle cells isolated from larger resistance
arterioles from the renal cortex. In CsCl-loaded cells, calcium influx
occurred through voltage-regulated pathways and induced a secondary
current carried by Cl
. The latter was blocked by
chelation of intracellular calcium or the chloride channel blocker DIDS.
Cl
channel blockade with niflumic acid or IAA-94 reversed
ANG II constriction of OMDVR (Fig. 7). Cl channel blockers seem to
reverse constriction in renal arterioles as well. Jensen and colleagues
(15, 16) found that DIDS had little effect on unstimulated vessels but reversed ANG II-induced afferent arteriolar constriction. With the use of the juxtamedullary nephron preparation and the isolated, perfused hydronephrotic kidney, respectively, Carmines (5) and Takenaka et al. (35) showed that
IAA-94 blocked ANG II-induced afferent but not efferent arteriolar
constriction. In our hands, reduction of
[Cl
]o enhanced ANG II-induced constriction
(Fig. 8). The effects of reducing extracellular chloride on ANG
II-induced constriction of the afferent arteriole have also been
investigated. Takenaka et al. (35) reduced external
Cl
from 114 to 51 mM and enhanced ANG II-induced
constriction by 20%. Restoration of intracellular chloride to
arterioles, previously depleted by incubation in gluconate, revived
contractile responses to high [KCl]o (15).
With the use of single-channel recording techniques, we identified a
probable Cl
channel in the plasma membrane of OMDVR
pericytes (Figs. 9 and 10). Several of this channel's characteristics
suggest that it mediates depolarization of pericytes by ANG II,
although we recognize that this is not proven. First, the low open
probability of this channel in the absence of ANG II stimulation (Fig.
10) mirrors the lack of effect of chloride substitution and channel
blockers on resting potential (Figs. 3 and 6) and vessel diameters
(Fig. 7). Second, ANG II activates this channel (Fig. 10) and
depolarizes pericytes (Figs. 4 and 5). The difficulty in finding this
channel in membrane patches has thus far made more extensive study of its control impractical.
Regulation of blood flow and microvascular pressures in the kidney is vital to enable fine control of glomerular filtration, salt and water handling, extracellular fluid volume, and blood pressure. Given this fact, it is perhaps not surprising that vasoconstrictors exert their actions on renal resistance vessels through various signal-transduction pathways involving varied ion channel architecture. Membrane depolarization through chloride channel activation has been described in the renal afferent arteriole (5, 13, 15, 16). In contrast, the efferent arteriole constricts normally in the presence of chloride channel blockers (5) and fails to depolarize when treated with ANG II (21). On this basis, the actions of ANG II in OMDVR more closely resemble those in the afferent arteriole, a result that contrasts with the origination of OMDVR from juxtamedullary efferent arterioles. Thus these data confirm that vasoconstrictors exert segment-specific actions not only in resistance vessels from the cortex, but also in DVR from the renal medulla.
In summary, the principal findings of this study are that constriction of OMDVR by ANG II involves activation of chloride channels in the plasma membrane of smooth muscle or pericytes. This leads to membrane depolarization that can be reversed by chloride channel blockade. OMDVR constriction is at least partly dependent on this process, because chloride channel blockers not only prevent depolarization but also reverse vasoconstriction. Finally, a chloride channel activated by ANG II has been identified in the pericyte plasma membrane and is likely to contribute to outward chloride currents and membrane depolarization.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by National Institutes of Health Grants DK-42495 and HL-62220.
| |
FOOTNOTES |
|---|
Present address of M. R. Turner: University of Liverpool, Liverpool L69 3GE, UK.
Address for reprint requests and other correspondence: T. L. Pallone, Division of Nephrology, N3W143, Univ. of Maryland at Baltimore, 22 S. Greene St., Baltimore, MD 21201-1595 (E-mail: tpallone{at}medicine.umaryland.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 18 September 2000; accepted in final form 9 February 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Adams, DJ.
Ionic channels in vascular endothelial cells.
Trends Cardiovasc Med
4:
18-26,
1994.
2.
Archer, SL,
Huang JMC,
Reeve HL,
Hampl V,
Tolarova S,
Michelakis E,
and
Weir EK.
Differential distribution of electrophysiologically distinct myocytes in conduit and resistance arteries determines their response to nitric oxide and hypoxia.
Circ Res
78:
431-442,
1996
3.
Astill, DS,
Rychkov G,
Clarke JD,
Hughes BP,
Roberts ML,
and
Bretag AH.
Characteristics of skeletal muscle chloride channel C1C-1 and point mutation R304E expressed in Sf-9 insect cells.
Biochim Biophys Acta
1280:
178-186,
1996[Medline].
4.
Brauner, T,
Hulser DF,
and
Strasser RJ.
Comparative measurements of membrane potentials with microelectrodes and voltage-sensitive dyes.
Biochim Biophys Acta
771:
208-216,
1984[Medline].
5.
Carmines, PK.
Segment-specific effect of chloride channel blockade on rat renal arteriolar contractile responses to angiotensin II.
Am J Hypertens
8:
90-94,
1995[ISI][Medline].
6.
Carmines, PK,
Fowler BC,
and
Bell PD.
Segmentally distinct effects of depolarization on intracellular [Ca2+] in renal arterioles.
Am J Physiol Renal Fluid Electrolyte Physiol
265:
F677-F685,
1993
7.
Cowley, AW.
Role of the renal medulla in volume and arterial blood pressure regulation.
Am J Physiol Regulatory Integrative Comp Physiol
273:
R1-R15,
1997
8.
Cupples, WA,
Sakai T,
and
Marsh DJ.
Angiotensin II and prostaglandins in control of vasa recta blood flow.
Am J Physiol Renal Fluid Electrolyte Physiol
254:
F417-F424,
1988
9.
Curry, FE.
Modulation of permeability by calcium influx into endothelial cells.
FASEB J
6:
2456-2466,
1992[Abstract].
10.
Dall'Asta, V,
Gatti R,
Orlandini G,
Rossi PA,
Rotoli BM,
Sala R,
Bussolati O,
and
Gazzola GC.
Membrane potential changes visualized in complete growth media through confocal laser scanning microscopy of bis-oxonol loaded cells.
Exp Cell Res
231:
260-268,
1997[ISI][Medline].
11.
Faubert, PF,
Chou SY,
and
Porush JG.
Regulation of papillary plasma flow by angiotensin II.
Kidney Int
32:
472-478,
1987[ISI][Medline].
12.
Fuentes, E,
Nadal A,
Jacob R,
and
McNaughton P.
Actions of serum and plasma albumin on intracellular Ca2+ in human endothelial cells.
J Physiol
504:
315-326,
1997[ISI][Medline].
13.
Gordienko, DV,
Clausen C,
and
Goligorsky MS.
Ionic currents and endothelin signaling in smooth muscle cells from rat renal resistance arteries.
Am J Physiol Renal Fluid Electrolyte Physiol
266:
F325-F341,
1994
14.
He, P,
and
Curry FE.
Measurement of membrane potential of endothelial cells in single perfused microvessels.
Microvasc Res
50:
183-198,
1995[ISI][Medline].
15.
Jensen, BL,
Ellekvist P,
and
Skott O.
Chloride is essential for contraction of afferent arterioles after agonists and potassium.
Am J Physiol Renal Physiol
272:
F389-F396,
1997
16.
Jensen, BL,
and
Skott O.
Blockade of chloride channels by DIDS stimulates renin release and inhibits contraction of afferent arterioles.
Am J Physiol Renal Fluid Electrolyte Physiol
270:
F718-F727,
1996
17.
Kirkup, AJ,
Edwards G,
Green ME,
Miller M,
Walker SD,
and
Weston AH.
Modulation of membrane currents and mechanical activity by niflumic acid in rat vascular smooth muscle.
Eur J Pharmacol
317:
165-174,
1996[ISI][Medline].
18.
Lamb, FS,
and
Barna TJ.
The endothelium modulates the contribution of chloride currents to norepinephrine-induced vascular contraction.
Am J Physiol Heart Circ Physiol
275:
H161-H168,
1998
19.
Large, WA,
and
Wang Q.
Characteristics and physiological role of the Ca2+-activated Cl
conductance in smooth muscle.
Am J Physiol Cell Physiol
271:
C435-C454,
1996
20.
Lemley, KV,
and
Kriz W.
Cycles and separations: the histotopography of the urinary concentrating process.
Kidney Int
31:
538-548,
1987[ISI][Medline].
21.
Loutzenhiser, R,
Chilton L,
and
Trotter G.
Membrane potential measurements in renal afferent and efferent arterioles: actions of angiotensin II.
Am J Physiol Renal Physiol
273:
F307-F314,
1997
22.
Marrero, MB,
Schieffer B,
Bernstein KE,
and
Ling BN.
Angiotensin II induced tyrosine phosphorylation in mesangial and vascular smooth muscle cells.
Clin Exp Pharmacol Physiol
23:
83-88,
1996[ISI][Medline].
23.
Nilius, B,
Szucs G,
Heinke S,
Voets T,
and
Droogmans G.
Multiple types of chloride channels in bovine pulmonary artery endothelial cells.
J Vasc Res
34:
220-228,
1997[ISI][Medline].
24.
Pallone, TL.
Vasoconstriction of outer medullary vasa recta by angiotensin II is modulated by prostaglandin E2.
Am J Physiol Renal Fluid Electrolyte Physiol
266:
F850-F857,
1994
25.
Pallone, TL,
Robertson CR,
and
Jamison RL.
Renal medullary microcirculation.
Physiol Rev
70:
885-920,
1990
26.
Pallone, TL,
Silldorff EP,
and
Cheung JY.
Response of isolated rat descending vasa recta to bradykinin.
Am J Physiol Heart Circ Physiol
274:
H752-H759,
1998
27.
Pallone, TL,
Silldorff EP,
and
Turner MR.
Intrarenal blood flow: microvascular anatomy and the regulation of medullary perfusion.
Clin Exp Pharmacol Physiol
25:
383-392,
1998[ISI][Medline].
28.
Pallone, TL,
Silldorff EP,
and
Zhang Z.
Inhibition of calcium signaling in descending vasa recta endothelia by ANG II.
Am J Physiol Heart Circ Physiol
278:
H1248-H1255,
2000
29.
Pallone, TL,
Work J,
Myers RL,
and
Jamison RL.
Transport of sodium and urea in renal outer medullary vascular bundles.
J Clin Invest
93:
212-222,
1994.
30.
Park, F,
Mattson DL,
Roberts LA,
and
Cowley AW, Jr.
Evidence for the presence of smooth muscle
-actin within pericytes of the renal medulla.
Am J Physiol Regulatory Integrative Comp Physiol
273:
R1742-R1748,
1997
31.
Quinn, K,
and
Beech DJ.
A method for direct patch clamp recording from smooth muscle cells embedded in functional brain microvessels.
Pflügers Arch
435:
564-569,
1998[ISI][Medline].
32.
Roman, RJ,
Kaldunski ML,
Scicli AG,
and
Carretero OA.
Influence of kinins and angiotensin II on the regulation of papillary blood flow.
Am J Physiol Renal Fluid Electrolyte Physiol
255:
F690-F698,
1988
33.
Stockand, JD,
and
Sansom SC.
Glomerular mesangial cells: electrophysiology and regulation of contraction.
Physiol Rev
78:
723-744,
1998
34.
Takenaka, T,
Epstein M,
Forster H,
Landry DW,
Iijima K,
and
Goligorsky MS.
Attenuation of endothelin effects by a chloride channel inhibitor, indanyloxyacetic acid.
Am J Physiol Renal Fluid Electrolyte Physiol
262:
F799-F806,
1992
35.
Takenaka, T,
Kanno Y,
Kitamura Y,
Hayashi K,
Suzuki H,
and
Saruta T.
Role of chloride channels in afferent arteriolar constriction.
Kidney Int
50:
864-872,
1996[ISI][Medline].
36.
Van Renterghem, C,
and
Lazdunski M.
Endothelin and vasopressin activate low-conductance chloride channels in aortic smooth muscle cells.
Pflügers Arch
425:
156-163,
1993[ISI][Medline].
37.
White, CR,
Elton TS,
Shoemaker RL,
and
Brock TA.
Calcium sensitive chloride channels in vascular smooth muscle cells.
Proc Soc Exp Biol Med
208:
255-262,
1995[Abstract].
This article has been cited by other articles:
![]() |
Q. Zhang, C. Cao, Z. Zhang, W. G. Wier, A. Edwards, and T. L. Pallone Membrane current oscillations in descending vasa recta pericytes Am J Physiol Renal Physiol, March 1, 2008; 294(3): F656 - F666. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cao, W. Lee-Kwon, K. Payne, A. Edwards, and T. L. Pallone Descending vasa recta endothelia express inward rectifier potassium channels Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1248 - F1255. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, C. Cao, M. Mangano, Z. Zhang, E. P. Silldorff, W. Lee-Kwon, K. Payne, and T. L. Pallone Descending vasa recta endothelium is an electrical syncytium Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1688 - R1699. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Loutzenhiser Inward rectifier currents in pericytes Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2006; 290(6): R1598 - R1600. [Full Text] [PDF] |
||||
![]() |
C. Cao, J. H. Goo, W. Lee-Kwon, and T. L. Pallone Vasa recta pericytes express a strong inward rectifier K+ conductance Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2006; 290(6): R1601 - R1607. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Lombard A novel mechanism for regulation of retinal blood flow by lactate: gap junctions, hypoxia, and pericytes Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H921 - H922. [Full Text] [PDF] |
||||
![]() |
C. Cao, W. Lee-Kwon, E. P. Silldorff, and T. L. Pallone KATP channel conductance of descending vasa recta pericytes Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1235 - F1245. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, C. Cao, W. Lee-Kwon, and T. L. Pallone Descending vasa recta pericytes express voltage operated Na+ conductance in the rat J. Physiol., September 1, 2005; 567(2): 445 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Szaszi, G. Sirokmany, C. D. Ciano-Oliveira, O. D. Rotstein, and A. Kapus Depolarization induces Rho-Rho kinase-mediated myosin light chain phosphorylation in kidney tubular cells Am J Physiol Cell Physiol, September 1, 2005; 289(3): C673 - C685. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Pallone, C. Cao, and Z. Zhang Inhibition of K+ conductance in descending vasa recta pericytes by ANG II Am J Physiol Renal Physiol, December 1, 2004; 287(6): F1213 - F1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Steendahl, N.-H. Holstein-Rathlou, C. M. Sorensen, and M. Salomonsson Effects of chloride channel blockers on rat renal vascular responses to angiotensin II and norepinephrine Am J Physiol Renal Physiol, February 1, 2004; 286(2): F323 - F330. |